 Matthew Jackman
Concepts (260)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Weight Gain | 15 | 2019 | 453 | 1.820 |
Why?
| | Obesity | 23 | 2022 | 2508 | 1.510 |
Why?
| | Energy Metabolism | 24 | 2021 | 731 | 1.460 |
Why?
| | Weight Loss | 11 | 2021 | 642 | 1.430 |
Why?
| | Dietary Fats | 13 | 2018 | 287 | 1.400 |
Why?
| | Caloric Restriction | 4 | 2019 | 90 | 0.920 |
Why?
| | Adipocytes | 5 | 2022 | 188 | 0.790 |
Why?
| | Adipose Tissue | 10 | 2022 | 545 | 0.730 |
Why?
| | Mitochondria, Muscle | 4 | 2019 | 93 | 0.660 |
Why?
| | Energy Intake | 13 | 2020 | 427 | 0.590 |
Why?
| | Physical Conditioning, Animal | 5 | 2020 | 194 | 0.540 |
Why?
| | Diet, High-Fat | 9 | 2018 | 225 | 0.530 |
Why?
| | Muscle, Skeletal | 13 | 2022 | 1473 | 0.510 |
Why?
| | Diet, Fat-Restricted | 5 | 2013 | 73 | 0.510 |
Why?
| | Body Weight | 6 | 2020 | 869 | 0.460 |
Why?
| | Rats, Wistar | 11 | 2021 | 368 | 0.390 |
Why?
| | Lipid Metabolism | 7 | 2017 | 444 | 0.370 |
Why?
| | Fatty Liver | 5 | 2018 | 211 | 0.370 |
Why?
| | Diet, Reducing | 1 | 2011 | 76 | 0.360 |
Why?
| | Rats | 18 | 2021 | 4959 | 0.340 |
Why?
| | Lactation | 3 | 2018 | 149 | 0.330 |
Why?
| | Liver | 8 | 2019 | 1637 | 0.320 |
Why?
| | Genes, Mitochondrial | 1 | 2008 | 12 | 0.300 |
Why?
| | NADH Dehydrogenase | 1 | 2008 | 17 | 0.300 |
Why?
| | Fatty Acids | 4 | 2021 | 381 | 0.290 |
Why?
| | Triglycerides | 6 | 2015 | 467 | 0.290 |
Why?
| | Intra-Abdominal Fat | 1 | 2008 | 77 | 0.280 |
Why?
| | Animals | 34 | 2022 | 31710 | 0.270 |
Why?
| | Physical Exertion | 3 | 2011 | 209 | 0.270 |
Why?
| | Overweight | 2 | 2022 | 472 | 0.260 |
Why?
| | Menopause | 3 | 2019 | 271 | 0.250 |
Why?
| | Lipoprotein Lipase | 2 | 2021 | 54 | 0.240 |
Why?
| | Oxidative Phosphorylation | 3 | 2016 | 155 | 0.240 |
Why?
| | Adaptation, Physiological | 4 | 2015 | 483 | 0.240 |
Why?
| | Polymorphism, Genetic | 1 | 2008 | 610 | 0.240 |
Why?
| | Subcutaneous Fat | 2 | 2015 | 70 | 0.230 |
Why?
| | Milk | 3 | 2018 | 124 | 0.230 |
Why?
| | Exercise | 4 | 2018 | 1644 | 0.210 |
Why?
| | Fructokinases | 2 | 2013 | 29 | 0.210 |
Why?
| | Oxidation-Reduction | 6 | 2011 | 923 | 0.200 |
Why?
| | Ovary | 2 | 2017 | 191 | 0.200 |
Why?
| | Oxygen Consumption | 4 | 2019 | 588 | 0.200 |
Why?
| | Mitochondria | 5 | 2022 | 747 | 0.200 |
Why?
| | Leptin | 2 | 2022 | 210 | 0.200 |
Why?
| | Acetyl-CoA Carboxylase | 2 | 2014 | 33 | 0.190 |
Why?
| | Prenatal Exposure Delayed Effects | 3 | 2018 | 452 | 0.190 |
Why?
| | Mentally Ill Persons | 1 | 2021 | 13 | 0.180 |
Why?
| | Ovariectomy | 4 | 2019 | 116 | 0.180 |
Why?
| | Homeostasis | 3 | 2015 | 573 | 0.180 |
Why?
| | Motor Activity | 2 | 2019 | 639 | 0.180 |
Why?
| | alpha-Linolenic Acid | 1 | 2000 | 7 | 0.180 |
Why?
| | Stearic Acids | 1 | 2000 | 12 | 0.180 |
Why?
| | Oleic Acid | 1 | 2000 | 30 | 0.170 |
Why?
| | Body Composition | 4 | 2019 | 590 | 0.170 |
Why?
| | Appetite | 1 | 2020 | 52 | 0.170 |
Why?
| | Fasting | 2 | 2000 | 241 | 0.170 |
Why?
| | Muscle Fibers, Slow-Twitch | 2 | 2016 | 13 | 0.160 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2021 | 185 | 0.160 |
Why?
| | Muscle Fibers, Fast-Twitch | 2 | 2016 | 15 | 0.160 |
Why?
| | Lipogenesis | 1 | 2019 | 56 | 0.160 |
Why?
| | Body Weight Maintenance | 1 | 2019 | 15 | 0.160 |
Why?
| | Thermogenesis | 1 | 2019 | 37 | 0.160 |
Why?
| | Diet | 3 | 2018 | 1080 | 0.160 |
Why?
| | Global Health | 1 | 2021 | 287 | 0.150 |
Why?
| | Physical Endurance | 2 | 2016 | 232 | 0.150 |
Why?
| | Cold Temperature | 1 | 2019 | 126 | 0.150 |
Why?
| | Mitochondria, Liver | 2 | 2013 | 67 | 0.150 |
Why?
| | Diglycerides | 1 | 2018 | 53 | 0.150 |
Why?
| | Rats, Sprague-Dawley | 4 | 2010 | 2219 | 0.150 |
Why?
| | Cholesterol | 1 | 2019 | 367 | 0.150 |
Why?
| | Eating | 1 | 2020 | 344 | 0.150 |
Why?
| | Recurrence | 4 | 2019 | 935 | 0.140 |
Why?
| | Sphingolipids | 1 | 2018 | 57 | 0.140 |
Why?
| | Postprandial Period | 2 | 2015 | 87 | 0.140 |
Why?
| | Adipogenesis | 1 | 2017 | 42 | 0.140 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2017 | 45 | 0.140 |
Why?
| | Metabolic Diseases | 1 | 2018 | 98 | 0.140 |
Why?
| | Mental Health Services | 1 | 2021 | 317 | 0.140 |
Why?
| | Male | 21 | 2021 | 55669 | 0.130 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2018 | 141 | 0.130 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2017 | 122 | 0.130 |
Why?
| | Catecholamines | 1 | 1996 | 94 | 0.130 |
Why?
| | Insulin | 3 | 2022 | 2082 | 0.130 |
Why?
| | Caffeine | 1 | 1996 | 57 | 0.130 |
Why?
| | Bone Density | 1 | 2019 | 432 | 0.130 |
Why?
| | Lipectomy | 1 | 2015 | 7 | 0.120 |
Why?
| | Carbon Radioisotopes | 3 | 2006 | 36 | 0.120 |
Why?
| | Thigh | 1 | 2015 | 53 | 0.120 |
Why?
| | Central Nervous System Stimulants | 1 | 1996 | 139 | 0.120 |
Why?
| | Breast Feeding | 1 | 2018 | 368 | 0.120 |
Why?
| | Female | 21 | 2022 | 59573 | 0.120 |
Why?
| | Mice | 11 | 2022 | 14872 | 0.120 |
Why?
| | Hyperlipidemias | 1 | 2015 | 121 | 0.120 |
Why?
| | Disease Models, Animal | 6 | 2019 | 3535 | 0.110 |
Why?
| | Time Factors | 4 | 2019 | 6114 | 0.110 |
Why?
| | Transcription Factors | 3 | 2019 | 1528 | 0.110 |
Why?
| | Glycogen | 2 | 2008 | 51 | 0.110 |
Why?
| | Sucrose | 1 | 2013 | 92 | 0.110 |
Why?
| | Physical Fitness | 1 | 2014 | 179 | 0.100 |
Why?
| | Exercise Tolerance | 1 | 2014 | 213 | 0.100 |
Why?
| | Hormones | 2 | 2010 | 132 | 0.100 |
Why?
| | Mothers | 2 | 2018 | 651 | 0.100 |
Why?
| | Insulin Resistance | 2 | 2018 | 1072 | 0.100 |
Why?
| | Blood Glucose | 2 | 2018 | 1828 | 0.100 |
Why?
| | Estradiol | 1 | 2014 | 455 | 0.090 |
Why?
| | Mammary Neoplasms, Animal | 1 | 2011 | 28 | 0.090 |
Why?
| | Appetite Regulation | 1 | 2011 | 26 | 0.090 |
Why?
| | Glucose Transporter Type 1 | 1 | 2011 | 42 | 0.090 |
Why?
| | Models, Biological | 2 | 2016 | 1621 | 0.090 |
Why?
| | Estrous Cycle | 1 | 2010 | 14 | 0.090 |
Why?
| | Metabolism | 1 | 2010 | 35 | 0.090 |
Why?
| | Citric Acid Cycle | 2 | 2003 | 43 | 0.090 |
Why?
| | Membrane Proteins | 2 | 2013 | 1019 | 0.090 |
Why?
| | Biopsy | 2 | 2018 | 1036 | 0.090 |
Why?
| | Neural Pathways | 1 | 2011 | 261 | 0.080 |
Why?
| | Sex Characteristics | 3 | 2018 | 641 | 0.080 |
Why?
| | Cell Proliferation | 3 | 2017 | 2187 | 0.080 |
Why?
| | Dietary Carbohydrates | 2 | 2009 | 138 | 0.080 |
Why?
| | Metabolic Syndrome | 1 | 2012 | 321 | 0.080 |
Why?
| | Adiponectin | 2 | 2022 | 213 | 0.080 |
Why?
| | Estrogen Receptor alpha | 1 | 2009 | 121 | 0.080 |
Why?
| | Mice, Inbred C57BL | 5 | 2018 | 4694 | 0.080 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2008 | 18 | 0.080 |
Why?
| | Adiposity | 4 | 2015 | 458 | 0.070 |
Why?
| | Basal Metabolism | 1 | 2008 | 46 | 0.070 |
Why?
| | Hyperplasia | 1 | 2008 | 163 | 0.070 |
Why?
| | Metabolic Networks and Pathways | 2 | 2022 | 168 | 0.070 |
Why?
| | Humans | 13 | 2022 | 114711 | 0.070 |
Why?
| | Estrogens | 1 | 2009 | 312 | 0.070 |
Why?
| | Carbon Dioxide | 2 | 2006 | 218 | 0.070 |
Why?
| | Palmitates | 1 | 2006 | 16 | 0.070 |
Why?
| | Breeding | 1 | 2006 | 55 | 0.070 |
Why?
| | Adult | 8 | 2022 | 30562 | 0.070 |
Why?
| | Pyruvic Acid | 2 | 2003 | 42 | 0.070 |
Why?
| | Intestinal Absorption | 1 | 2006 | 93 | 0.060 |
Why?
| | Down-Regulation | 1 | 2008 | 594 | 0.060 |
Why?
| | Photoperiod | 2 | 2019 | 48 | 0.060 |
Why?
| | Enteral Nutrition | 1 | 2006 | 160 | 0.060 |
Why?
| | Rabbits | 2 | 1996 | 733 | 0.060 |
Why?
| | Endoplasmic Reticulum | 2 | 2018 | 234 | 0.060 |
Why?
| | Phosphorylation | 1 | 2008 | 1569 | 0.060 |
Why?
| | Pregnancy | 4 | 2018 | 5520 | 0.050 |
Why?
| | Perilipin-2 | 2 | 2013 | 36 | 0.050 |
Why?
| | Animals, Newborn | 2 | 2017 | 778 | 0.050 |
Why?
| | Indians, North American | 1 | 2008 | 570 | 0.050 |
Why?
| | Fructose | 2 | 2013 | 100 | 0.050 |
Why?
| | Diphtheria Toxin | 1 | 2022 | 51 | 0.050 |
Why?
| | In Vitro Techniques | 3 | 2003 | 1016 | 0.050 |
Why?
| | RNA, Messenger | 2 | 2019 | 2553 | 0.050 |
Why?
| | Calorimetry, Indirect | 2 | 2011 | 69 | 0.050 |
Why?
| | Exercise Test | 2 | 2009 | 544 | 0.040 |
Why?
| | Digestive System | 1 | 2000 | 27 | 0.040 |
Why?
| | Feeding Behavior | 2 | 2018 | 575 | 0.040 |
Why?
| | Betaine | 2 | 2013 | 63 | 0.040 |
Why?
| | Uncoupling Protein 1 | 1 | 2019 | 15 | 0.040 |
Why?
| | Iodide Peroxidase | 1 | 2019 | 27 | 0.040 |
Why?
| | Hematopoietic Stem Cells | 1 | 2022 | 343 | 0.040 |
Why?
| | Adipose Tissue, Brown | 1 | 2019 | 43 | 0.040 |
Why?
| | Fever | 1 | 2000 | 280 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 386 | 0.040 |
Why?
| | Phenotype | 1 | 2006 | 2797 | 0.040 |
Why?
| | Bile Acids and Salts | 1 | 2019 | 171 | 0.040 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2019 | 270 | 0.040 |
Why?
| | Breast Neoplasms | 1 | 2009 | 1862 | 0.040 |
Why?
| | Cohort Studies | 1 | 2008 | 4895 | 0.040 |
Why?
| | Sarcolemma | 1 | 2018 | 29 | 0.040 |
Why?
| | Adenosine Triphosphate | 2 | 2016 | 430 | 0.040 |
Why?
| | Perilipin-1 | 1 | 2017 | 16 | 0.040 |
Why?
| | Models, Animal | 1 | 2019 | 344 | 0.040 |
Why?
| | Cell Size | 1 | 2017 | 80 | 0.040 |
Why?
| | Nutritional Status | 1 | 2000 | 287 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2011 | 9089 | 0.040 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2017 | 60 | 0.040 |
Why?
| | Temperature | 1 | 2000 | 565 | 0.040 |
Why?
| | Cytosol | 1 | 2018 | 208 | 0.040 |
Why?
| | Glucose Clamp Technique | 1 | 2018 | 181 | 0.040 |
Why?
| | Running | 1 | 2019 | 207 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2018 | 343 | 0.030 |
Why?
| | Phosphocreatine | 1 | 2016 | 36 | 0.030 |
Why?
| | PPAR gamma | 1 | 2017 | 182 | 0.030 |
Why?
| | Creatine Kinase | 1 | 2016 | 75 | 0.030 |
Why?
| | Mice, Knockout | 2 | 2013 | 2570 | 0.030 |
Why?
| | Physical Conditioning, Human | 1 | 2016 | 27 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2022 | 1076 | 0.030 |
Why?
| | Norepinephrine | 1 | 1996 | 201 | 0.030 |
Why?
| | Ethanol | 1 | 2000 | 538 | 0.030 |
Why?
| | Electron Transport | 1 | 1996 | 108 | 0.030 |
Why?
| | Middle Aged | 4 | 2018 | 26740 | 0.030 |
Why?
| | Subcutaneous Fat, Abdominal | 1 | 2015 | 13 | 0.030 |
Why?
| | Double-Blind Method | 2 | 1996 | 1660 | 0.030 |
Why?
| | Lactic Acid | 1 | 1996 | 275 | 0.030 |
Why?
| | Circadian Rhythm | 2 | 2009 | 356 | 0.030 |
Why?
| | Fatty Acid Synthases | 1 | 2014 | 23 | 0.030 |
Why?
| | Choline | 1 | 1995 | 106 | 0.030 |
Why?
| | Bicycling | 1 | 1995 | 86 | 0.030 |
Why?
| | Proteins | 2 | 2013 | 908 | 0.030 |
Why?
| | Rats, Inbred Strains | 1 | 2014 | 362 | 0.030 |
Why?
| | Body Temperature | 1 | 1994 | 208 | 0.030 |
Why?
| | Homocysteine S-Methyltransferase | 1 | 2013 | 5 | 0.030 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2013 | 42 | 0.030 |
Why?
| | Cell Respiration | 1 | 2013 | 74 | 0.030 |
Why?
| | DNA Methylation | 1 | 2017 | 496 | 0.030 |
Why?
| | Mammary Glands, Animal | 1 | 2014 | 117 | 0.030 |
Why?
| | Fatigue | 1 | 1995 | 294 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2017 | 1131 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1994 | 511 | 0.030 |
Why?
| | Meals | 1 | 2014 | 104 | 0.030 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2014 | 172 | 0.030 |
Why?
| | Sex Factors | 1 | 2018 | 1715 | 0.030 |
Why?
| | Disease Susceptibility | 1 | 2014 | 316 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1314 | 0.020 |
Why?
| | Isoenzymes | 1 | 2012 | 283 | 0.020 |
Why?
| | Immunoblotting | 1 | 2011 | 283 | 0.020 |
Why?
| | Calcium | 1 | 2016 | 1108 | 0.020 |
Why?
| | Methylnitrosourea | 1 | 2009 | 6 | 0.020 |
Why?
| | Proteome | 1 | 2013 | 340 | 0.020 |
Why?
| | Thermodynamics | 2 | 2003 | 382 | 0.020 |
Why?
| | Mice, Nude | 1 | 2011 | 630 | 0.020 |
Why?
| | Alkylating Agents | 1 | 2009 | 27 | 0.020 |
Why?
| | Receptor, ErbB-2 | 1 | 2011 | 300 | 0.020 |
Why?
| | Interleukin-4 | 1 | 2009 | 206 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 993 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2011 | 1226 | 0.020 |
Why?
| | Interleukin-2 | 1 | 2009 | 413 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 4411 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2013 | 1313 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2011 | 1629 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2014 | 3886 | 0.020 |
Why?
| | Glucose | 1 | 2011 | 897 | 0.020 |
Why?
| | Carbohydrate Metabolism | 1 | 2006 | 48 | 0.020 |
Why?
| | Cell Line | 1 | 2011 | 2637 | 0.020 |
Why?
| | Rats, Zucker | 1 | 2005 | 27 | 0.020 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2005 | 47 | 0.020 |
Why?
| | Lipid Peroxidation | 1 | 2005 | 139 | 0.020 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2005 | 84 | 0.010 |
Why?
| | Methionine | 1 | 2005 | 144 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 2711 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2015 | 2128 | 0.010 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2018 | 2093 | 0.010 |
Why?
| | Risk Factors | 1 | 2017 | 8634 | 0.010 |
Why?
| | Glycolysis | 1 | 2005 | 227 | 0.010 |
Why?
| | Malates | 1 | 2003 | 5 | 0.010 |
Why?
| | Glutathione | 1 | 2005 | 293 | 0.010 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2005 | 473 | 0.010 |
Why?
| | Reperfusion Injury | 1 | 2005 | 255 | 0.010 |
Why?
| | Disease Progression | 1 | 2009 | 2382 | 0.010 |
Why?
| | Carbon | 1 | 2003 | 156 | 0.010 |
Why?
| | Inflammation | 1 | 2013 | 2480 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 2320 | 0.010 |
Why?
| | Pyruvate Carboxylase | 1 | 2000 | 2 | 0.010 |
Why?
| | Fluorescence Polarization | 1 | 2000 | 35 | 0.010 |
Why?
| | Radioisotope Dilution Technique | 1 | 2000 | 13 | 0.010 |
Why?
| | Kinetics | 1 | 2003 | 1551 | 0.010 |
Why?
| | Intracellular Membranes | 1 | 2000 | 73 | 0.010 |
Why?
| | Hydrolysis | 1 | 2000 | 173 | 0.010 |
Why?
| | Tissue Distribution | 1 | 2000 | 286 | 0.010 |
Why?
| | Young Adult | 1 | 2014 | 10472 | 0.010 |
Why?
| | Alcohol Drinking | 1 | 2000 | 652 | 0.010 |
Why?
| | Cross-Over Studies | 1 | 1995 | 440 | 0.010 |
Why?
| | Administration, Oral | 1 | 1995 | 729 | 0.010 |
Why?
|
|
Jackman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|